Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Advances in the Management of Ulcerative Colitis (UC)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
Research in Ulcerative Colitis (UC) 2024
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Brazil, India, Mexico, Saudi Arabia, Taiwan, Turkey
Research in Ulcerative Colitis (UC) 2024
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Research Oncology USA
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)
Release Date:
Partner: American College of Emergency Physicians (ACEP)
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
HER2 Expression in Urothelial Carcinoma (UC)
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Hospital Benin, Congo, The Democratic Republic
Title
Grant Type
Focus Area
Country
Application Due Date
INNOVAtive Multi-disciplinary Clinical Management of INflammatory Diseases, 2023 IT INNOVA-MIND
Release Date:
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology Italy
Quality Improvement in Pediatric Endocrinology Fields
Release Date:
Partner: The Japanese Society for Pediatric Endocrinology
Review Process: Expert Review Panel
Quality Improvement Rare Disease Japan
Biomarker Testing / Lung Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
Employment Support / Lung Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology Japan
2023 Oncology Fellowship
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Fellowship Oncology Canada
Approaches to Implement Bispecific Antibodies into Clinical Practice, Increase Awareness and Improve Delivery of Quality of Care
Release Date:
Partner: Mylenoma Canada
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Improving Health Equity via Clinical Trial Capability Development in China
Release Date:
Review Process: Pfizer Internal
Education Support for the Professions China
Combination Therapy with Relugolix in the Treatment of Advanced Prostate Cancer
Release Date:
Partner: National Comprehensive Cancer Network; Myovant Sciences
Review Process: Expert Review Panel
Research Oncology USA
Optimizing Women’s Health Conditions in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Internal Medicine Canada
Women’s Health
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Education Internal Medicine Canada
Accelerating Advancements in Women’s Health
Release Date:
Partner: Myovant Sciences
Review Process: Expert Review Panel
Research Internal Medicine USA
Implementing Rapid Turnaround Time for NGS Molecular Testing for Cancer Patients in Non-Academic and Community Centres
Release Date:
Partner: Colorectal Cancer Canada and Thermo Fisher Scientific
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada